Generex Biotechnology Corporation news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

GNBT 3.50 0.00 (0.00%)
price chart
3.50
Generex Biotechnology Corp. engages in the research, development and commercialization of drug delivery systems and technologies.
Generex Biotechnology Corporation (OTCMKTS:GNBT) On The Comeback Trail
Generex Biotechnology Corporation (OTCMKTS:GNBT), the biotech player, is looking to make a comeback. The Yahoo Finance Forum, the iHub Forum, and Seeking Alpha stocktalks are full of comments about the news put out by the company.
Yutaka Niihara, MD, MPH, CEO of Emmaus, Appointed Executive Chairman of ...
TORRANCE, Calif., Jan. 25, 2017 /PRNewswire/ -- Emmaus announced today that its Chairman and Chief Executive Officer, Yutaka Niihara, MD, MPH, has joined the Board of Directors of Generex Biotechnology Corporation ("Generex", OTCPink: GNBT) as ...
ADDING MULTIMEDIA Generex Welcomes Dr. Yutaka Niihara, MD, MPH to Its Board ...  Yahoo Finance
Emmaus Life Sciences, Inc. Enters into Collaborative Agreement with Generex ...
TORRANCE, Calif., Jan. 24, 2017 /PRNewswire/ -- Emmaus announced today that it has entered into a letter of intent (the "LOI") to establish a collaborative agreement with Generex Biotechnology Corporation ("Generex", OTCPink: GNBT). Emmaus will sell ...
Is Generex Now A Cannabis Play?
Generex Biotechnology Corp. (OTCPK:GNBT) has long been a disappointment to its investors. Its share price currently stands at US$0.02.
A Look at Generex Biotechnology Corporation (OTCMKTS:GNBT)
Generex Biotechnology Corporation (OTCMKTS:GNBT) has continued to move lower in recent months continuing a trend that has lasted for years.
Here's What Matters Right Now For Generex Biotechnology Corporation (OTCMKTS:GNBT)
Generex Biotechnology Corporation (OTCMKTS:GNBT) rocketed from $0.004 a share to $0.015 between January 20 and January 25, as the company announced it had signed an LOI to acquire a controlling interest in an entity called Emmaus Life Sciences, ...
Deconstructing The Generex Biotechnology Corporation (OTCMKTS:GNBT) Pivot
Between January 20 and January 25, Generex Biotechnology Corporation (OTCMKTS:GNBT) ran up from around $0.0045 a share, to $0.012 a share - a more than 166% gain.
Spotlight on Generex Biotechnology Corporation (OTCMKTS:GNBT)
Generex Biotechnology Corporation (OTCMKTS:GNBT) is one penny stock that has got Investors attention as it continues to trade moderate volume just below the $0.01 mark.
A Waking Bull: Generex Biotechnology Corporation (OTCMKTS:GNBT)
Generex Biotechnology Corporation (OTCMKTS:GNBT) has seen a recent jump in volume as the stock moves over the $0.02 mark. The stock has been upward bound since hitting an all-time low of $0.0105 in January.